ACECOR

ACECOR

ACECOR

DESCRIPTION
Anti-inflammatory corticosteroid, intermediate action formulated based on Triamcinolone acetonide.

COMPOSITION
Triamcinolone, acetonide: 0.6 g.
Excipients csp: 100 ml.

ACTION
Anti-inflammatory corticosteroid systemic action.
Antipruritic systemic action.
Antiallergic Antirheumatic

INDICATIONS
In all those muscular and skeletal conditions due to inflammation: bursitis, tendinitis, myositis, arthritis, neuritis.
Dermopathies: dermatosis, atopic dermatitis, dermatological processes in general.
Ophthalmic conditions: Iridocyclitis, uveitis, blepharitis, chorioretinitis, optic neuritis.
Ketosis in cattle and sheep.
Allergic processes: allergic dermatitis, anaphylactic shock.

ACECOR

CONTRAINDICATIONS
Do not use in viral infections.
Avoid its use in animals with Tuberculosis or with a history of chronic Nephritis or Cushing’s syndrome.
In bacterial infectious processes its use must be accompanied by the corresponding anti-infective therapy.
Do not use the intrasynovial route in acute infectious processes.
It is suggested not to administer during pregnancy.

RESTRICTIONS OF USE
Do not administer to dairy cattle if the milk is destined for human consumption.
Do not administer in equines intended for consumption.

SIDE EFFECTS AND ADVERSE REACTIONS
The main complication of prolonged use of corticosteroids is the appearance of Cushing’s Syndrome and hypoadrenocorticism if sudden interruption occurs.
There may be delayed healing of wounds, predisposition to infectious diseases, exacerbation of diabetes mellitus, growth retardation in young animals and in dogs can be polyuria and polyphagia, weight gain, changes in the coat, vomiting, diarrhea, euphoria and changes in behavior These symptoms disappear when discontinuing or stopping treatment.

DOSAGE
Dogs and cats: intramuscular and subcutaneous via 0.2 to 0.4 ml per 10 kg of live weight in the case of arthritis, and 0.4 ml per 10 kg of live weight in the case of dermopathies.
Cattle: intramuscular route 3 to 5 total ml.
Equine: intramuscular, subcutaneous, intraarticular or intrasynovial via 2 to 3.5 total ml.

Leave a Reply

Your email address will not be published. Required fields are marked *